It’s a hat trick for Pegasus!
October 16, 2014 |
Pegasus scoops the much-coveted “Consultancy of the Year” prize at the PR Week Awards 2014
Pegasus, the UK’s leading independent health communications consultancy, picked up the prestigious “Consultancy of the Year” award at Tuesday night’s PR Week Awards 2014.
Pegasus was also successful in the “Mid-Sized Consultancy of the Year” category (for agencies with UK turnover between £2m and £10m), and completed its hat trick winning the “Healthcare: Ethical & OTC Consumer” award for its work on Bayer Animal Health’s Slimewatch campaign.
This win marks Pegasus’s evolution from a traditional PR agency to an integrated comms consultancy that offers a multiservice approach to its clients, including social, digital and creative services.
With campaigns that span local, national and international markets and the creation of a network of global independent affiliate agencies across five continents, it’s no surprise that Pegasus represents a raft of well known companies and brands such as GSK, Pfizer, Bayer, Holland & Barrett, Bio-Oil and Danone to name a few. These awards are further confirmation that the consultancy continues to go from strength to strength, creating outstanding integrated campaigns that really bring healthcare into the mainstream. This is the third consultancy award win for the agency this year.
It has seen five years of double-digit growth, with last year’s fee income of £6m helping it climb ten places in this year’s PR Week Top 150 PR Consultancies report to number 38.
Fishburn CEO, Ali Gee said: “Pegasus has everything; it’s clear who they are, what they do and what makes them special.
Their purpose – inspiring health decisions – defines everything they do, and we were particularly impressed by the way they have reached beyond the healthcare sector.” 
Lisa Bradley, managing director at Pegasus, commented: “We’re absolutely delighted to have won, not just one, but three awards at the PR Week Awards this year. I’ve always looked at the winners of the “Consultancy of the Year” award with great admiration and am so proud that we are now that agency.”
ENDS
For more information please contact Maria Boiling or Amy Simmons at Pegasus on 01273 712000 or mboiling@thisispegasus.co.uk / asimmons@thisispegasus.co.uk
Notes to editors
Located in Brighton with a 75-strong team of communications experts, Pegasus specialises in helping the public and private sector communicate healthy messages through integrated communications programmes. Focusing on an overall mission to ‘Inspire Healthy Decisions’ and driven by a health first, sector second approach, Pegasus has a demonstrative track record of creating and implementing campaigns that inspire change.
The Pegasus approach to planning starts by investing time understanding the varied nature of decisions in every area of people’s day to day lives, from the general public through to the healthcare professionals that treat and the policy makers that shape the environment in which they work. The consultancy’s fully integrated approach blends unrivalled health contacts across the international, national, consumer, regional and specialist press, with in-house corporate, creative, social and digital services.
Pegasus’s clients currently include GSK, Pfizer, Boehringer Ingelheim, Bayer, Thornton & Ross, Holland & Barrett, Sanofi, Bio-Oil, Danone, Homedics, Novo Nordisk and Pierre Fabre. For more information please visit www.thisispegasus.co.uk.
This content was provided by Inizio
Company Details
Latest Content from Inizio
Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series
Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.
Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025
As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...
How DataGateway unified oncology data for real-world insights & market intelligence
Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.
Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.
Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.
ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement
Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.
Preparing for ASH 2025: Pharma’s role in hematology innovation
As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...
AI without limits: A smarter, integrated approach to Medical Affairs
At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...
What to expect from Obesity Week 2025: Key trends shaping the future of obesity care
Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.
AI with intent: How Inizio is redefining pharma through precision and partnership
At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the...
Leading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight
Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.